|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating activities | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Stock-based compensation | |||||
| Amortization of issuance costs on convertible senior notes | |||||
| Provision for inventory write-downs | |||||
| Provision (benefit) for deferred income taxes | |||||
| Loss on divestitures | |||||
| Provision for credit losses | |||||
| Unrealized loss on equity investments | |||||
| Fair value adjustments to contingent consideration obligations | |||||
| Gain on sale of building | |||||
| Building | |||||
| PPE Excluding Building | |||||
| Foreign currency transaction effect on income | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Inventory and other deferred costs | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable and other liabilities | |||||
| Accrued interest | |||||
| Net cash provided by operating activities | |||||
| Investing activities | |||||
| Purchases of short-term marketable securities | |||||
| Purchases of property and equipment | |||||
| Payments related to acquisitions, net of cash acquired | |||||
| Proceeds from sale of building | |||||
| Proceeds from sales of short-term marketable securities | |||||
| Net cash used in investing activities | |||||
| Financing activities | |||||
| Proceeds from issuance of convertible senior notes, net of issuance costs paid of $3,234 | |||||
| Costs paid related to issuance of convertible senior notes | |||||
| Convertible Senior Notes | |||||
| Total costs paid related to issuance of convertible senior notes | |||||
| Common stock cash dividend paid | |||||
| Proceeds from issuance of common stock | |||||
| Proceeds from stock option exercises | |||||
| Payment of withholding taxes in connection with net settlement of equity awards | |||||
| Deferred payments for acquisitions | |||||
| Payments of long-term debt | |||||
| Net cash (used in) provided by financing activities | |||||
| Effect of exchange rate changes on cash and cash equivalents | |||||
| Net increase in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of period | |||||
| Cash and cash equivalents at end of period | |||||
Loading...